Cargando…

Changing trends in pharmacology…

Detalles Bibliográficos
Autor principal:	Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497435/ https://www.ncbi.nlm.nih.gov/pubmed/28706326 http://dx.doi.org/10.4103/0253-7613.208138

Ejemplares similares

Social Pharmacology and its impact on clinics
por: Bansal, Seema, et al.
Publicado: (2021)

Connectomics: A pharmacologic viewpoint
por: Harikrishnareddy, Dibbanti, et al.
Publicado: (2018)

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

Photopharmacology
por: Sarma, Phulen, et al.
Publicado: (2017)

New undergraduate medical education curriculum
por: Mittal, Niti, et al.
Publicado: (2022)

Changing trend in the use of antimicrobials over ten years in a tertiary care hospital
por: Bansal, Vishal, et al.
Publicado: (2011)

Ecopharmacovigilance: An issue urgently to be addressed
por: Medhi, Bikash, et al.
Publicado: (2012)

Orphan drugs: Indian perspective
por: Kumar, Harish, et al.
Publicado: (2017)

Cosmetovigilance in India: Need of the day
por: Sarma, Phulen, et al.
Publicado: (2017)

Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
por: Singh, Harvinder, et al.
Publicado: (2020)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

mHealth technologies in clinical trials: Opportunities and challenges
por: Kakkar, Ashish Kumar, et al.
Publicado: (2018)

Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations
por: Goyal, Pardeep Kumar, et al.
Publicado: (2020)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Marathon mice: Researcher view on potential roles in preclinical research
por: Kumaravel, J., et al.
Publicado: (2021)

Impact of Organization for Economic Co-Operation and Development (OECD) principles of Good Laboratory practices (GLP) in India
por: Kapoor, Ekta, et al.
Publicado: (2021)

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Genomic biomarkers: Unveiling the potential for precise cancer therapy response
por: Kaur, Gurjeet, et al.
Publicado: (2023)

Concept of essential medicines and recent updates
por: Gupta, Shreya, et al.
Publicado: (2023)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Modulation of endocannabinoid system: Success lies in the failures
por: Kumar, Subodh, et al.
Publicado: (2018)

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Developing and sustaining India's capacity for preclinical drug discovery
por: Lewis, David I., et al.
Publicado: (2018)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Monkeypox infection: A quick glance
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Trends in Pharmacological Sciences Looks Ahead in 2021 and Beyond
por: Mukherjee, Kusumika
Publicado: (2021)

Collaborative research in modern era: Need and challenges
por: Bansal, Seema, et al.
Publicado: (2019)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

Integrative omics – An arsenal for drug discovery
por: Singh, Rahul Soloman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kdbhmlqgcjkeft98u0mv0emrj7